Mitochondrial Long Non-Coding RNAs in Gynecological Cancers: Pathogenic Signaling Pathways and Therapeutic...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Gynecological cancers present significant challenges due to late-stage diagnosis and complex molecular drivers.
• Nuclear long non-coding RNAs (lncRNAs) are implicated in tumor progression, metastasis, and therapy resistance in these cancers.
• Mitochondrial dysfunction and lncRNAs are critical in tumor cell survival, metabolic adaptation, and stress response.

Purpose of the Study:

• To review the regulatory mechanisms of mitochondrial lncRNAs in ovarian, cervical, and endometrial cancers.
• To consolidate current knowledge on mitochondrial lncRNA functions in gynecological malignancies.
• To identify novel research avenues and therapeutic targets.

Main Methods:

• Literature review focusing on mitochondrial lncRNAs in gynecological cancers.
• Analysis of molecular mechanisms involving mitochondrial lncRNAs.
• Synthesis of data on mitochondrial-nuclear communication.

Main Results:

• Nuclear lncRNAs modulate chromatin, microRNAs, and mitochondrial dynamics, promoting cancer progression.
• Mitochondrial lncRNAs (mt-lncRNAs) are involved in retrograde signaling, respiration, and apoptosis regulation.
• Dysregulated mt-lncRNAs impact tumor bioenergetics, mitochondrial integrity, and gene expression.

Conclusions:

• Mitochondrial lncRNAs play a significant role in the development and progression of gynecological cancers.
• Elucidating mt-lncRNA functions in mitochondrial-nuclear crosstalk can lead to new interventions.
• mt-lncRNAs show potential as diagnostic biomarkers and therapeutic targets in gynecological oncology.